Eli Lilly and Co (LLY)

Add to Watchlists
Create an Alert
128.16 +1.57  +1.24% NYSE Mar 20, 16:59 Delayed 2m USD
View Full Chart
LLY Price Chart
View All Key Stats

LLY Key Stats

View All LLY News

LLY News

View All Events

LLY Events

Date Type Description
02/13/2020 09:00 EST Misc Eli Lilly and Co Fourth Quarter Earnings Conference Call in 2019
02/13/2020 Earnings Eli Lilly and Co Fourth Quarter Earnings in 2019 Release
10/23/2019 09:00 EDT Misc Eli Lilly and Co Third Quarter Earnings Conference Call in 2019
10/23/2019 Earnings Eli Lilly and Co Third Quarter Earnings Results in 2019
07/30/2019 09:00 EDT Misc Eli Lilly and Co Second Quarter Earnings Conference Call in 2019
07/30/2019 Earnings Eli Lilly and Co Second Quarter Earnings Results in 2019
04/30/2019 09:00 EDT Misc Eli Lilly and Co First Quarter Earnings Conference Call in 2019
04/30/2019 Earnings Eli Lilly and Co First Quarter Earnings Results in 2019
02/14/2019 Dividends Amount: 0.645, Declared Date: Dec 19 2018, Pay Date: Mar 08 2019
02/13/2019 09:00 EST Misc Eli Lilly and Co Fourth Quarter Earnings Conference Call in 2018
View All Performance Charts

LLY Total Returns Comparison

LLY Fundamentals

Income Statement View Statement

Revenue (TTM) 24.56B
Total Expenses (TTM) 18.13B
Net Income (TTM) 3.232B

Balance Sheet View Statement

Total Assets (Quarterly) 43.91B
Total Liabilities (Quarterly) 33.00B
Shareholders Equity (Quarterly) 9.829B

Cash Flow Statement View Statement

Cash from Operations (TTM) 5.524B
Cash from Investing (TTM) 1.906B
Cash from Financing (TTM) -5.905B

LLY Ratings

Advertisement

LLY One Page Reports

LLY Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 128.16
Price Target Upgrade
Price Target Upside (Daily) Upgrade
Edit

Profile

  • URL: http://www.lilly.com
  • Investor Relations URL: https://investor.lilly.com/
  • HQ State/Province: Indiana
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Apr. 30, 2019
  • Last Earnings Release: Feb. 13, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Feb. 14, 2019
  • Description: Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Cialis for erectile dysfunction. Also, Lilly holds a strong position in the animal pharmaceutical market, which it plans to divest in late 2018.

LLY Comparables

Edit
AMGN Amgen Inc
BIIB Biogen Inc
CELG Celgene Corp
GILD Gilead Sciences Inc
JNJ Johnson & Johnson

LLY Excel Add-In Codes

  • Name: =YCI("LLY","name")
  • Description: =YCI("LLY","description")
  • Sector: =YCI("LLY","sector")
  • Industry: =YCI("LLY","industry")
  • Est. Current Fiscal Year End: =YCI("LLY","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Other LLY Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.